Back

Adjunctive low-dose intracoronary thrombolysis during primary PCI in STEMI: an updated meta-analysis of randomised controlled trials

30 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Evolving strategies in coronary revascularisation: from devices to procedural optimisation Adjunctive Pharmacotherapy ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Miss Sayeli Elisa Martinez-Topete

Tijuana (Mexico)

5 More presentations in this session

Presentation thumbnail
Bioadaptor versus contemporary drug-eluting stents: Meta-analysis of randomized controlled trials
Doctor O. Kumet (Van, TR)
Abstract Slides Video
Presentation thumbnail
Does pre-dilatation balloon choice matter? standard versus specialized balloons prior to drug-coated balloon therapy in acute coronary syndrome patients
Doctor A. Darwish (Makkah, SA)
Abstract Slides Video
Presentation thumbnail
Drug-coated balloons versus drug-eluting stents following coronary atherectomy in severely calcified lesions: a systematic review and meta-analysis
Doctor A. Dos Santos Cleto (Indaiatuba, BR)
Abstract Slides Video
Presentation thumbnail
Length-to-diameter ratio predicts target lesion revascularization in patients undergoing percutaneous coronary intervention
Doctor V. Radl (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Determinants of suboptimal functional revascularization after primary PCI in STEMI: a prospective cohort study
Doctor B. Tas Ozbek (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Evolving strategies in coronary revascularisation: from devices to procedural optimisation

The Event

Event poster

ESC Congress 2026

30 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Unmasking the specificity paradox: why pharmacological class, not the strategy, defines success in intracoronary thrombolysis for stemi (role of fibrin specificity following the STRIVE trial)
28 August 2026
thumbnail
Congress Presentation
GLP-1 receptor agonists reduce infarct size relative to area at risk in myocardial infarction: a meta-analysis of randomized controlled trials
30 August 2026
thumbnail
Congress Presentation
Efficacy and safety of short (≤6 months) versus prolonged (>6 months) dual antiplatelet therapy following percutaneous coronary intervention: a systematic review and meta-analysis
30 August 2026
thumbnail
Congress Presentation
Periprocedural efficacy and safety comparison between ultrasound‑assisted catheter‑directed thrombolysis and catheter‑directed mechanical thrombectomy for acute pulmonary embolism
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources